Distinct effects of NPY13-36, a specific NPY Y2 agonist, in a model of rodent endotoxemia on leukocyte subsets and cytokine levels

This study indicates distinct subset- and cytokine-specific in vivo effects induced by an NPY Y2 receptor specific treatment after a short-term LPS challenge.